United States· US:0168-0416_a63cc4f4-5aba-4e02-915a-5535f2b625aa
Tacrolimus
A medicinal product containing tacrolimus, registered in United States by E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TACROLIMUS
- Manufacturer
- E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1101680416301 TUBE in 1 CARTON (0168-0416-30) / 30 g in 1 TUBE
- ndc1101680416601 TUBE in 1 CARTON (0168-0416-60) / 60 g in 1 TUBE
- ndc1101680416991 TUBE in 1 CARTON (0168-0416-99) / 100 g in 1 TUBE
- ndc110168-0416-30
- ndc110168-0416-60
- ndc110168-0416-99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacrolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsTacrolimus Accord 1 mg/g zalfAccord Healthcare B.V.
- SwedenTacrolimus STADA 1 mg/g SalvaSTADA Arzneimittel AG
- SwitzerlandTakrozem 1 mg/g, SalbePierre Fabre Pharma SA
- SpainCELLMUNE 1 MG/G POMADAIndustrial Farmaceutica Cantabria S.A.
- FinlandTacrolimus STADASTADA Arzneimittel AG
- CzechiaADVAGRAFAstellas Pharma Europe B.V., Leiden
- United KingdomAdoport 0.5mg capsulesSandoz Ltd
- PolandAdvagrafAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Ireland · Prograf, Tacrolimus Accord
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5ee7e8f-2c41-41e3-b892-55aa48032cda GET /v1/drugs/e5ee7e8f-2c41-41e3-b892-55aa48032cda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "TACROLIMUS",
"productndc": "0168-0416",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "ANDA200744",
"marketing_category": "ANDA"
}See everything about tacrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.